| PERIOD ENDING | 28-Feb-09 | 29-Feb-08 | 28-Feb-07 | | Total Revenue | 3,092 | 3,593 | 3,610 | | Cost of Revenue | 1,444 | 1,404 | 1,454 | | | Gross Profit | 1,647 | 2,189 | 2,156 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 1,252 | 1,235 | 1,281 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 396 | 954 | 875 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 71 | 174 | 88 | | Earnings Before Interest And Taxes | 467 | 1,128 | 963 | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | 467 | 1,128 | 963 | | Income Tax Expense | 139 | 404 | 341 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 328 | 724 | 623 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 328 | 724 | 623 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $328 | $724 | $623 |
|
0.50% Nasdaq 
Income Statement
